Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
48.35
-1.17 (-2.36%)
May 28, 2026, 2:33 PM EDT - Market open
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
130.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| Black Diamond Therapeutics | 70.00M |
| Equillium | 4.39M |
| NRx Pharmaceuticals | 2.29M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| Cardiff Oncology | 525.00K |
| Connect Biopharma Holdings | 233.00K |
SPRB News
- 22 hours ago - Spruce Biosciences to Participate in Upcoming Conferences in June - Business Wire
- 7 days ago - Spruce Biosciences Transcript: AGM 2026 - Transcripts
- 14 days ago - Spruce Biosciences price target lowered to $150 from $170 at Citizens - TheFly
- 15 days ago - Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11) - TheFly
- 15 days ago - Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates - Business Wire
- 15 days ago - Spruce Biosciences Earnings release: Q1 2026 - Filings
- 15 days ago - Spruce Biosciences Quarterly report: Q1 2026 - Filings
- 24 days ago - Spruce Biosciences appoints Brian Walls as VP, market access - TheFly